The primary regulatory body responsible for pharmaceuticals in Liechtenstein is the Office of Health and Social Affairs. Communication on the delayed recognition of Swiss marketing authorizations for medicinal products with new active pharmaceutical ingredients in Liechtenstein Due to its accession to the EEA, Liechtenstein also accepts medicinal products that have been reviewed and approved by the EU in the central. Pharmaceutical regulations in Liechtenstein play a crucial role in safeguarding public health and ensuring the quality, safety, and efficacy of medicinal products. Liechtenstein, is a tiny country between Austria, and Switzerland. The country has a universal healthcare system that covers not only citizens but everyone residing within its borders. Moreover, the healthcare standard is high, well-developed and the citizens suffer from few. For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI. With a structured doctoral programme, diverse research projects and tailor-made continuing education courses.
[PDF Version]